Growth Hormone Administration to Improve Reproductive Outcomes in Women with Recurrent Implantation Failure (RIF): a Systematic Review

Maira Vera-Montoya, Jose Andrés Calvache*, Selmo Geber

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Recurrent implantation failure (RIF) has been used to describe embryos’ failure to implant following IVF, arising concerns about the importance of its treatment. Growth hormone (GH) has been studied as one of the possible co-interventions. Our updated review evaluated GH intervention vs. no intervention from randomized controlled trials (RCTs) in RIF patients. Electronic searches on The Menstrual Disorders and Subfertility Group (MDSG), The Cochrane Central Register for Clinical Trials, PubMed MEDLINE, EMBASE, PsycINFO, CINAHL, LILACS, and Google Scholar up to August 2021 identified 2 RCTs and compiled with the above inclusion criteria. The risk of bias (ROB) and the quality of evidence were assessed according to the Cochrane Collaboration tool and GRADE group guidelines. Meta-analysis found higher rates of clinical pregnancy (OR: 4.97 CI 95% 2.05 to 12.05), live birth (OR: 5.13 CI 95% 2.03 to 12.91), and implantation (OR: 3.88 CI 95% 1.91 to 7.88) when compared GH to no intervention; as well as an increased endometrial thickness (mean difference: 1.14 CI 95% -0.0 to 2.28). However, this review cannot provide a strong recommendation due to the quality of evidence rated as “very low quality of evidence” in all the outcomes for reasons such as methodology issues, heterogeneity, intervention regimen, and limited sample sizes with large confidence intervals and a low number of events. We emphasize the importance of upcoming high-quality research and the need for consensus concepts in RIF patients, which may be a minority; it is still one of the highest impacts on life quality.

Original languageEnglish
Pages (from-to)1712-1723
Number of pages12
JournalReproductive Sciences
Volume30
Issue number6
Early online date5 Dec 2022
DOIs
Publication statusPublished - Jun 2023

Bibliographical note

Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Society for Reproductive Investigation.

Fingerprint

Dive into the research topics of 'Growth Hormone Administration to Improve Reproductive Outcomes in Women with Recurrent Implantation Failure (RIF): a Systematic Review'. Together they form a unique fingerprint.

Cite this